NCT07785609
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07785609
Title A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
Acronym MK-2010
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CHE

Facility Status City State Zip Country Details
START San Antonio ( Site 0220) RECRUITING San Antonio Texas 78229 United States Details
Queen Mary Hospital ( Site 2300) RECRUITING Hong Kong Hong Kong Details
Ospedale Regionale Bellinzona e Valli ( Site 1102) RECRUITING Bellinzona Canton Ticino 6500 Switzerland Details
Cantonal Hospital St.Gallen ( Site 1100) RECRUITING Sankt Gallen 9007 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field